Showing results (131-140 of 172) with videos related to
Sort By:
Pageof 18
International Journal of Cancer|June 25, 2009
The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasmsClaire Borie, Chrystelle Colas, Peggy Dartigues, et al.Blood|May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.Cancer Discovery|April 20, 2022
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell LymphomagenesisWilfred Leung, Matt Teater, Ceyda Durmaz, et al.Biorxiv : the Preprint Server for Biology|August 13, 2025
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Stenberg cells reveals escape from NK cell recognition and an unfolded protein responseMikhail Roshal, Isabella Y Kong, Wikum Dinalankara, et al.The Lancet. Haematology|August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trialPaul G Rubinstein, Page C Moore, Milan Bimali, et al.Blood|December 22, 2009
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.Blood|May 16, 2008
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemiaIlaria V Libani, Ella C Guy, Luca Melchiori, et al.The Journal of Clinical Investigation|May 24, 2008
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumorsSergey V Shmelkov, Jason M Butler, Andrea T Hooper, et al.The Journal of Experimental Medicine|June 3, 2026
eIF3e-mediated translational checkpoint maintains immune tolerance and prevents lymphoid malignancyLianghua Lin, Pengda Chen, Jiazhen Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern eraAndrew M Evens, Kevin A David, Irene Helenowski, et al.Pageof 18